TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9709290

Group type: EXPERIMENTAL
Intervention: Breast cancer screening (mammograms)
Number of subjects: 1000
Study: 7935276

Group type: EXPERIMENTAL
Intervention: Vitamin A as retinol palmitate (300,000 UI a day for the first year and 150,000 UI for the second year)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (600 mg a day for two years)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Both vitamin A and N-acetylcysteine
Number of subjects: 29

Group type: COMPARATOR
Intervention: No drugs (control group)
Number of subjects: 29
Study: 3060232

Group type: EXPERIMENTAL
Intervention: 2% hydroxypropyl methylcellulose
Number of subjects: 84

Group type: COMPARATOR
Intervention: 1% sodium hyaluronate
Number of subjects: 84
Study: 30629306

Group type: EXPERIMENTAL
Intervention: Swallowing therapy program initiated within 1 year post-radiotherapy
Number of subjects: 117

Group type: COMPARATOR
Intervention: Swallowing therapy program initiated after 2 years post-radiotherapy
Number of subjects: 117
Study: 29208991

Group type: EXPERIMENTAL
Intervention: Active HD-tDCS (20 mins)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham HD-tDCS (40 seconds)
Number of subjects: 50
Study: 25176002

Group type: EXPERIMENTAL
Intervention: 6-minute walk test (6MWT) at home
Number of subjects: 19

Group type: COMPARATOR
Intervention: 6-minute walk test (6MWT) at hospital
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Shorter track length at home
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Increased number of turns during home test
Number of subjects: 19
Study: 23255685

Group type: EXPERIMENTAL
Intervention: Locally-prepared ready-to-use therapeutic food (LRUTF)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Locally-prepared F100 diet
Number of subjects: 98
Study: 20828829

Group type: EXPERIMENTAL
Intervention: iStent trabecular micro‐bypass stent with cataract surgery
Number of subjects: 240

Group type: COMPARATOR
Intervention: Cataract surgery only
Number of subjects: 240
Study: 18006861

Group type: EXPERIMENTAL
Intervention: Electromechanical gait trainer (GT)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Electromechanical gait trainer with functional electrical stimulation (GT-FES)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Conventional overground gait training (CT)
Number of subjects: 54
Study: 16539086

Group type: EXPERIMENTAL
Intervention: Perioperative chemotherapy
Number of subjects: 2793

Group type: COMPARATOR
Intervention: No perioperative chemotherapy
Number of subjects: 2793
Study: 14610121

Group type: EXPERIMENTAL
Intervention: Normal allele at codon 171
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Asn171Ser variant allele
Number of subjects: 100
Study: 10993427

Group type: EXPERIMENTAL
Intervention: Water load test in dysmotility‐like functional dyspepsia patients
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Gastric dysrhythmias in dysmotility‐like functional dyspepsia patients
Number of subjects: 48

Group type: COMPARATOR
Intervention: Gastric dysrhythmias in control subjects
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Reproducibility of gastric myoelectrical activity
Number of subjects: 48
Study: 8790128

Group type: EXPERIMENTAL
Intervention: Centers for Disease Control and Prevention lead screening questionnaire
Number of subjects: 2978

Group type: EXPERIMENTAL
Intervention: Complete questionnaire used in Denver
Number of subjects: 2978

Group type: EXPERIMENTAL
Intervention: Blood lead levels greater than 0.96 mumol/L (20 micrograms/dL)
Number of subjects: 2978

Group type: EXPERIMENTAL
Intervention: Blood lead levels greater than 0.48 mumol/L (10 micrograms/dL)
Number of subjects: 2978
Study: 1644087

Group type: EXPERIMENTAL
Intervention: Nisoldipine (10 mg twice daily)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 6433495

Group type: EXPERIMENTAL
Intervention: BCAA enriched solution containing 50% of amino acids as BCAA
Number of subjects: 5

Group type: COMPARATOR
Intervention: Complete feeding solution containing 15.6% of amino acids as BCAA
Number of subjects: 5
Study: 30500967

Group type: EXPERIMENTAL
Intervention: Azithromycin (AZI)
Number of subjects: 613

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 613
Study: 30208157

Group type: EXPERIMENTAL
Intervention: Auriculotherapy
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control (routine care)
Number of subjects: 102
Study: 26269149

Group type: EXPERIMENTAL
Intervention: Military body armour (BA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No body armour (BA)
Number of subjects: 0
Study: 24901876

Group type: EXPERIMENTAL
Intervention: Unilateral vertebroplasty (VP)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Bilateral vertebroplasty (VP)
Number of subjects: 39
Study: 22430337

Group type: EXPERIMENTAL
Intervention: Nasal eosinophilia test
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no allergic rhinitis)
Number of subjects: 100
Study: 20082618

Group type: EXPERIMENTAL
Intervention: Nutritional intervention with hydrolysed infant formulas (partially or extensively hydrolysed whey, extensively hydrolysed casein (eHF-C), or standard cow's milk formula)
Number of subjects: 5991

Group type: EXPERIMENTAL
Intervention: Nutritional intervention with eHF-C formula
Number of subjects: 5991

Group type: COMPARATOR
Intervention: Non-interventional group (children without familial predisposition)
Number of subjects: 5991
Study: 18725223

Group type: EXPERIMENTAL
Intervention: High-definition, wide-angle endoscope (HDE)
Number of subjects: 693

Group type: COMPARATOR
Intervention: Standard colonoscope (SC)
Number of subjects: 693
Study: 15505639

Group type: EXPERIMENTAL
Intervention: SNPs in and around the GAD1 gene
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 4-SNP haplotypes
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: SNPs
Number of subjects: 72
Study: 12929894

Group type: EXPERIMENTAL
Intervention: CATCH intervention schools
Number of subjects: 76

Group type: COMPARATOR
Intervention: CATCH control schools
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Both school conditions
Number of subjects: 76
Study: 9805537

Group type: EXPERIMENTAL
Intervention: 20 mg furosemide
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 8533565

Group type: EXPERIMENTAL
Intervention: Hygroscopic tent
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gemeprost
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Misoprostol (administered orally 17 hours before vacuum curettage)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Misoprostol (administered orally 10 hours before vacuum curettage)
Number of subjects: 0
Study: 2376102

Group type: EXPERIMENTAL
Intervention: 2% zinc citrate/silica product
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Crest Tartar Control
Number of subjects: 187

Group type: COMPARATOR
Intervention: Crest Regular
Number of subjects: 187
Study: 74197

Group type: EXPERIMENTAL
Intervention: Polyvinyl alcohol 5%
Number of subjects: 22

Group type: COMPARATOR
Intervention: Liquid paraffin
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Rose bengal scoring (modified Bijsterveld method)
Number of subjects: 22
Study: 31436109

Group type: EXPERIMENTAL
Intervention: Water immersion during the first stage of labor
Number of subjects: 64

Group type: COMPARATOR
Intervention: Not submerged (control group)
Number of subjects: 64
Study: 30293352

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (loading dose of 1.0 μg/kg, followed by continuous infusion of 0.5 μg·kg(‐1)·h(‐1) until 20 min before the end of operation)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 120
Study: 28237612

Group type: EXPERIMENTAL
Intervention: Chondroitin sulfate (800mg/day)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 26200118

Group type: EXPERIMENTAL
Intervention: Scoliosis-specific exercises (SSE) with a home exercise plan
Number of subjects: 58

Group type: COMPARATOR
Intervention: Standard practice of advice and education
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Scoliosis-specific exercises (SSE)
Number of subjects: 58
Study: 23085116

Group type: EXPERIMENTAL
Intervention: Graded exercise treatment (GET)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Usual physiotherapy (UP)
Number of subjects: 151
Study: 21389329

Group type: EXPERIMENTAL
Intervention: Transdermal fluid (TDF) sampling following acute plyometric exercise
Number of subjects: 22

Group type: COMPARATOR
Intervention: Transdermal fluid (TDF) sampling following 60 min of cycling exercise at 60% Vo(2)(peak)
Number of subjects: 22
Study: 18513462

Group type: EXPERIMENTAL
Intervention: Varenicline (0.5-2.0 mg/day)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 320
Study: 17161727

Group type: EXPERIMENTAL
Intervention: Annual mammography to age 48 years
Number of subjects: 160921

Group type: COMPARATOR
Intervention: Usual medical care
Number of subjects: 160921
Study: 14570652

Group type: COMPARATOR
Intervention: IV saline 5 mL (Group I)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 40 mg of IV pantoprazole (Group II)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 50 mg of IV ranitidine (Group III)
Number of subjects: 90
Study: 11218969

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg/day
Number of subjects: 92

Group type: COMPARATOR
Intervention: Simvastatin 20 mg/day
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Cost-effectiveness of Atorvastatin
Number of subjects: 92
Study: 9778713

Group type: EXPERIMENTAL
Intervention: Modified ultrafiltration
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 8310975

Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg once daily
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 2458198

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (2 x 2 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 1563131

Group type: EXPERIMENTAL
Intervention: Combined treatment with propranolol 20 mg tid and diltiazem 60 mg tid
Number of subjects: 13
Study: 362831

Group type: EXPERIMENTAL
Intervention: i.v. L-tryptophan
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 20
Study: 31767788

Group type: EXPERIMENTAL
Intervention: Flavoured WP tobacco
Number of subjects: 144

Group type: COMPARATOR
Intervention: Non-flavoured WP tobacco
Number of subjects: 144
Study: 31295165

Group type: EXPERIMENTAL
Intervention: SBIRT (Substance Use Screening, Brief Intervention, and Referral to Treatment)
Number of subjects: 0
Study: 28323804

Group type: EXPERIMENTAL
Intervention: Ertl procedure
Number of subjects: 2

Group type: COMPARATOR
Intervention: Burgess procedure
Number of subjects: 2
Study: 25441594

Group type: EXPERIMENTAL
Intervention: Early oral refeeding (EORF)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Conventional oral refeeding (CORF)
Number of subjects: 146
Study: 25022371

Group type: EXPERIMENTAL
Intervention: Modified oral brush biopsy
Number of subjects: 225

Group type: COMPARATOR
Intervention: Exfoliative cytology
Number of subjects: 225
Study: 23001642

Group type: EXPERIMENTAL
Intervention: Web-based diabetes and nutritional intervention
Number of subjects: 180
Study: 19755938

Group type: EXPERIMENTAL
Intervention: Remifentanil (1.0 microg/kg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Normal saline (3 mL)
Number of subjects: 24
Study: 17322145

Group type: EXPERIMENTAL
Intervention: Once-daily mesalazine (1 x 4 g/d)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Twice-daily mesalazine (2 x 2 g/d)
Number of subjects: 30
Study: 15451744

Group type: EXPERIMENTAL
Intervention: Standard group
Number of subjects: 3081

Group type: EXPERIMENTAL
Intervention: Enhanced group
Number of subjects: 3081

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3081
Study: 11882333

Group type: EXPERIMENTAL
Intervention: 25 mg/day TRF25
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 50 mg/day TRF25
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 100 mg/day TRF25
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 200 mg/day TRF25
Number of subjects: 90

Group type: COMPARATOR
Intervention: AHA Step‐1 diet
Number of subjects: 90
Study: 9835980

Group type: EXPERIMENTAL
Intervention: Midazolam (0.07 mg.kg‐1, IM)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 9160577

Group type: EXPERIMENTAL
Intervention: Fenfluramine
Number of subjects: 43

Group type: COMPARATOR
Intervention: Clonidine
Number of subjects: 43

Group type: COMPARATOR
Intervention: Levodopa
Number of subjects: 43
Study: 2492286

Group type: EXPERIMENTAL
Intervention: No plaster cast or weight-bearing, and active exercises of the ankle
Number of subjects: 56

Group type: COMPARATOR
Intervention: Non-weight-bearing plaster cast
Number of subjects: 56

Group type: COMPARATOR
Intervention: Plaster walking cast for the first six postoperative weeks
Number of subjects: 56
Study: 1107512

Group type: EXPERIMENTAL
Intervention: Epinephrine
Number of subjects: 279

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 279
Study: 31482797

Group type: COMPARATOR
Intervention: Normal night's sleep
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Severe sleep deprivation
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Eye-blink parameters
Number of subjects: 12
Study: 28923223

Group type: EXPERIMENTAL
Intervention: Various treatment modalities for hepatocellular carcinoma
Number of subjects: 0
Study: 26228892

Group type: EXPERIMENTAL
Intervention: Iodixanol (n = 31)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Low-osmolal contrast media (n = 102)
Number of subjects: 133
Study: 23787519

Group type: EXPERIMENTAL
Intervention: Artemether
Number of subjects: 138

Group type: COMPARATOR
Intervention: Quinine
Number of subjects: 138
Study: 21753916

Group type: EXPERIMENTAL
Intervention: IRx intervention in NICU trial
Number of subjects: 299

Group type: COMPARATOR
Intervention: Routine information services (control) in NICU trial
Number of subjects: 299

Group type: COMPARATOR
Intervention: Routine information services (control) in BrCa trial
Number of subjects: 299
Study: 18850117

Group type: EXPERIMENTAL
Intervention: 1% zinc citrate dentifrice
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control formulation
Number of subjects: 30
Study: 16764620

Group type: COMPARATOR
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: LycoRed (2000 microg lycopene)
Number of subjects: 41
Study: 15218558

Group type: EXPERIMENTAL
Intervention: 100 mg diclofenac sodium softgel
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 100 mg diclofenac potassium (Cataflam)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 10845671

Group type: EXPERIMENTAL
Intervention: Prednisolone-primed IFN treatment (Group I)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: IFN treatment only (Group II)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo (Group III)
Number of subjects: 85
Study: 9120464

Group type: EXPERIMENTAL
Intervention: Patients with Parkinson's disease
Number of subjects: 25

Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 25
Study: 1302763

Group type: EXPERIMENTAL
Intervention: 16.4 mg iv prednisolone
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: 49.2 mg iv prednisolone
Number of subjects: 7

Group type: COMPARATOR
Intervention: No drug (baseline)
Number of subjects: 7
Study: 3886139

Group type: EXPERIMENTAL
Intervention: Fentiazac (100 mg QID)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Paracetamol (500 mg QID)
Number of subjects: 30
Study: 30316139

Group type: EXPERIMENTAL
Intervention: Baseline social support quality (positive support, negative interactions, conflict)
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Baseline social support quality
Number of subjects: 316

Group type: COMPARATOR
Intervention: Baseline social support
Number of subjects: 316
Study: 30020124

Group type: EXPERIMENTAL
Intervention: 3D computer-assisted planning
Number of subjects: 40

Group type: COMPARATOR
Intervention: 2D planning
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 3D planning
Number of subjects: 40
Study: 28659429

Group type: EXPERIMENTAL
Intervention: EVD plus intraventricular alteplase
Number of subjects: 500

Group type: COMPARATOR
Intervention: EVD plus saline
Number of subjects: 500
Study: 26149802

Group type: EXPERIMENTAL
Intervention: Allogeneic hematopoietic stem cell transplantation (allo-HSCT)
Number of subjects: 622
Study: 22892722

Group type: EXPERIMENTAL
Intervention: Ultra-low-dose chest computed tomography (ULD-CT) with model-based iterative reconstruction (MBIR)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Ultra-low-dose chest computed tomography (ULD-CT)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard dose diagnostic CT (SDD-CT)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Low-dose diagnostic CT (LDD-CT)
Number of subjects: 42
Study: 20651284

Group type: EXPERIMENTAL
Intervention: Diabetic patients (DM)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Endothelial miR-126 in diabetic patients
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Hyperglycemic Lep(ob) mice
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: High glucose concentrations
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Patients with DM
Number of subjects: 80
Study: 18262655

Group type: EXPERIMENTAL
Intervention: rTMS
Number of subjects: 46

Group type: COMPARATOR
Intervention: ECT
Number of subjects: 46
Study: 16841343

Group type: EXPERIMENTAL
Intervention: Fluoxetine (up to 40 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (during 1-week run-in)
Number of subjects: 60
Study: 12681451

Group type: EXPERIMENTAL
Intervention: Percutaneous vertebroplasty
Number of subjects: 79

Group type: COMPARATOR
Intervention: Conservative therapy
Number of subjects: 79
Study: 10097028

Group type: EXPERIMENTAL
Intervention: 50 mg naltrexone
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 11321183

Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV) and interferon‐alpha (IFN‐alpha) combination therapy at high dose (600 mg ZDV/6 MIU IFN‐alpha)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV) and interferon‐alpha (IFN‐alpha) combination therapy
Number of subjects: 34

Group type: COMPARATOR
Intervention: Interferon‐alpha (IFN‐alpha) monotherapy
Number of subjects: 34

Group type: COMPARATOR
Intervention: Zidovudine (ZDV) monotherapy
Number of subjects: 34
Study: 1816245

Group type: COMPARATOR
Intervention: Prophylactic blood transfusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Blood transfusion therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Excellent prenatal monitoring and aggressive intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prenatal diagnosis and cord blood screening
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prophylactic penicillin
Number of subjects: 0
Study: 6109857

Group type: EXPERIMENTAL
Intervention: Acetazolamide (500 mg daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 31296157

Group type: EXPERIMENTAL
Intervention: AKI cases (n=7)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: AKI prediction
Number of subjects: 84
Study: 28558695

Group type: EXPERIMENTAL
Intervention: Azithromycin (AZ)
Number of subjects: 1018

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 1018
Study: 26392160

Group type: EXPERIMENTAL
Intervention: Mass oral azithromycin distribution
Number of subjects: 0

Group type: COMPARATOR
Intervention: Expert survey estimation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bayesian analysis
Number of subjects: 0
Study: 23963850

Group type: EXPERIMENTAL
Intervention: Thrombus aspiration and intracoronary tirofiban
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional PCI
Number of subjects: 80
Study: 21277016

Group type: EXPERIMENTAL
Intervention: simvastatin 40 mg daily
Number of subjects: 20536

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20536
Study: 19372044

Group type: EXPERIMENTAL
Intervention: RITA used in Y-graft configuration
Number of subjects: 0
Study: 16569552

Group type: EXPERIMENTAL
Intervention: Lifestyle modification group (LG)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Advice group (Control)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: *825T allele carriers in LG
Number of subjects: 101
Study: 12473420

Group type: EXPERIMENTAL
Intervention: Intensified diet counseling
Number of subjects: 715

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 715
Study: 10693368

Group type: EXPERIMENTAL
Intervention: Glucosamine 500 mg three times daily
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study: 8252691

Group type: EXPERIMENTAL
Intervention: Combined supplementation with alpha-tocopherol (800 IU/d), ascorbate (1.0 g/d), and beta carotene (30 mg/d)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: COMPARATOR
Intervention: Alpha-tocopherol only (800 IU/d)
Number of subjects: 24
Study: 3099269

Group type: EXPERIMENTAL
Intervention: Lactobacilli-containing formula
Number of subjects: 30

Group type: COMPARATOR
Intervention: Non-lactobacilli-containing formula
Number of subjects: 30
Study: 30145512

Group type: COMPARATOR
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 439

Group type: COMPARATOR
Intervention: Fluoxetine (FLX)
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Combination of Cognitive-Behavioral Therapy and Fluoxetine (COMB)
Number of subjects: 439
Study: 26867045

Group type: EXPERIMENTAL
Intervention: Physical activity counseling intervention based on self-determination theory (SDT)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 67
Study: 24961881

Group type: EXPERIMENTAL
Intervention: Parents of caries-free children
Number of subjects: 981

Group type: COMPARATOR
Intervention: Parents of children with caries
Number of subjects: 981
Study: 22490589

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1.0 µg/kg over 10 minutes, maintenance dosage 0.7 µg×kg(‐1)×h(‐1))
Number of subjects: 60

Group type: COMPARATOR
Intervention: Propofol target-controlled infusion
Number of subjects: 60
Study: 20473244

Group type: EXPERIMENTAL
Intervention: Diaphragm use (immediate)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Observation before commencing diaphragm use (delayed)
Number of subjects: 140
Study: 18705232

Group type: EXPERIMENTAL
Intervention: Split-thickness skin grafts
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conservative wound dressing
Number of subjects: 100